Scarica l'app Stockscreener
0.6119
0.15%
-0.0009
Precedente Chiudi:
$0.6128
Aprire:
$0.62
Volume 24 ore:
779.19K
Relative Volume:
0.32
Capitalizzazione di mercato:
$112.32M
Reddito:
-
Utile/perdita netta:
$-111.13M
Rapporto P/E:
-0.4636
EPS:
-1.32
Flusso di cassa netto:
$-91.53M
1 W Prestazione:
-11.51%
1M Prestazione:
+24.88%
6M Prestazione:
-59.74%
1 anno Prestazione:
-78.97%
Intervallo 1D:
$0.6007
$0.6249
Intervallo di 1 settimana:
$0.592
$0.68
Portata 52W:
$0.36
$4.06
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Nome
Tenaya Therapeutics Inc
Settore
Industria
Telefono
415-865-2066
Indirizzo
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Confronta TNYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.6119 | 112.32M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-10 | Iniziato | William Blair | Outperform |
| 2023-11-30 | Iniziato | Leerink Partners | Outperform |
| 2022-06-15 | Iniziato | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Price Target at $6.25 - Defense World
Millennium Management LLC Sells 174,447 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) and Alpha Cognition (NASDAQ:ACOG) Critical Survey - Defense World
Squarepoint Ops LLC Decreases Stock Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Nuveen Asset Management LLC Buys 69,377 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Deutsche Bank AG Acquires 97,318 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Northern Trust Corp Grows Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics Appoints New Directors at Annual Meeting - TipRanks
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Average Target Price from Brokerages - Defense World
Price T Rowe Associates Inc. MD Sells 2,892,201 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock By Investing.com - Investing.com Nigeria
Tenaya Therapeutics chief medical officer sells $1,300 in stock By Investing.com - Investing.com Nigeria
Tenaya Therapeutics chief medical officer sells $1,300 in stock - Investing.com Australia
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock - Investing.com
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Tenaya Therapeutics Awards Major Stock Options Package: 461K Shares for Strategic New Hires - Stock Titan
Greenlane Renewables Announces First Quarter 2025 Financial Results - The Globe and Mail
Barclays PLC Sells 184,837 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (TNYA) to Showcase Key Research at ASGCT 2025 | TNYA Stock News - GuruFocus
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting - The Manila Times
Tenaya Therapeutics to Present Five Abstracts on Innovative Heart Disease Gene Therapies at ASGCT 2025 Annual Meeting - Nasdaq
Tenaya Therapeutics to Highlight Capsid Engineering, Gene - GlobeNewswire
Hsbc Holdings PLC Purchases New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Equities Analysts Issue Forecasts for TNYA Q2 Earnings - Defense World
Tenaya Therapeutics’ (TNYA) Buy Rating Reiterated at Chardan Capital - Defense World
We're A Little Worried About Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate - Yahoo Finance
Chardan Capital Maintains Buy Rating for Tenaya Therapeutics (TNYA) | TNYA Stock News - GuruFocus
Tenaya Therapeutics Reports Q1 2025 Financial Results - TipRanks
Tenaya (TNYA) Reports Promising Clinical Trial Developments and Financial Outlook | TNYA Stock News - GuruFocus
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
A Cautious Investment in the Drone Sector - The Globe and Mail
Geode Capital Management LLC Sells 27,419 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace
Why To Invest In Tenaya Therapeutics Inc (NASDAQ: TNYA) Stock? - Marketing Sentinel
H.C. Wainwright maintains Buy on Tenaya Therapeutics stock By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on Tenaya Therapeutics stock - Investing.com Australia
TNYATenaya Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Tenaya reports progress in ARVC gene therapy study - Investing.com
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025 - The Manila Times
Tenaya Therapeutics Presents Interim Data from RIDGE™ - GlobeNewswire
Major Breakthrough: 175-Patient ARVC Study Shows 93% Could Benefit from New Gene Therapy Treatment - Stock Titan
Strategy (MSTR) Buys Another $556 Million Worth of Bitcoin - The Globe and Mail
Tenaya Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com India
Tenaya Therapeutics faces Nasdaq delisting over share price - Investing.com Australia
Tenaya Therapeutics Inc Azioni (TNYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tenaya Therapeutics Inc Azioni (TNYA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
May 16 '25 |
Sale |
0.44 |
2,937 |
1,300 |
171,856 |
| Ali Faraz | Chief Executive Officer |
May 16 '25 |
Sale |
0.44 |
3,189 |
1,412 |
317,325 |
| Higa Tomohiro | SVP, Finance |
Mar 10 '25 |
Sale |
0.54 |
2,482 |
1,336 |
99,690 |
| Tingley Whittemore | Chief Medical Officer |
Mar 10 '25 |
Sale |
0.54 |
7,398 |
3,983 |
174,793 |
| Ali Faraz | Chief Executive Officer |
Mar 10 '25 |
Sale |
0.54 |
9,741 |
5,245 |
320,514 |
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):